Synergy CHC Corp. (SNYR)
1.81
+0.01
(+0.56%)
USD |
NASDAQ |
Jan 20, 16:00
1.50
-0.31
(-17.13%)
After-Hours: 20:00
Synergy CHC EPS Diluted (Quarterly): 0.0124 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NeOnc Technologies Holdings, Inc. | -0.4485 |
| NRX Pharmaceuticals, Inc. | -0.2649 |
| Acurx Pharmaceuticals, Inc. | -1.226 |
| BioVie, Inc. | -0.984 |
| Lantern Pharma, Inc. | -0.3856 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.1253M |
| Revenue (Quarterly) | 8.010M |
| Total Expenses (Quarterly) | 7.885M |
| Enterprise Value | 44.37M |
| Gross Profit Margin (Quarterly) | 70.50% |
| Profit Margin (Quarterly) | 1.56% |
| Earnings Yield | 16.13% |
| Operating Earnings Yield | 37.95% |
| Normalized Earnings Yield | 6.801 |